Insilico Medicine Hong Kong Limited

This early-stage study tests a new drug called ISM6331 in about 100 people with advanced mesothelioma or other solid tumors that have not responded to standard treatments. The main goals are to check the drug's safety, find the best dose, and see if it can shrink tumors. Particip…

This study tests a new drug called ISM5411 in 80 adults with active ulcerative colitis. The goal is to see if it is safe and helps control the disease. Participants will receive either the drug or a placebo, and researchers will monitor side effects and how well the drug works.

This early-phase study tests a new drug called ISM3412 in people with advanced solid tumors that have a specific genetic change (MTAP deletion). The main goals are to check the drug's safety and find the best dose. About 80 participants will take part in two stages: first to find…

This study tests an experimental oral drug called INS018_055 in 40 adults with idiopathic pulmonary fibrosis (IPF), a lung-scarring disease. The main goal is to check the drug's safety over 12 weeks. Participants will be randomly assigned to receive either the drug or a placebo, …